Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
04:11pm, Thursday, 14'th Aug 2025
Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem's financial team POMPANO BEACH, FL, August 14, 2
KMDA vs. ILMN: Which Stock Is the Better Value Option?
12:40pm, Thursday, 14'th Aug 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for thei
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know
10:16am, Tuesday, 05'th Aug 2025
Evaluate Illumina's (ILMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Illumina: The Stock Is Still Undervalued
04:23am, Monday, 04'th Aug 2025
Illumina exceeded Q2FY25 expectations and raised FY25 guidance, driven by resilient Chinese operations and strong clinical market growth, especially in oncology. The company is expanding into proteomi
Illumina (ILMN) Q2 EPS Jumps 9%
07:23pm, Friday, 01'st Aug 2025
Illumina (ILMN) Q2 EPS Jumps 9%
These Analysts Boost Their Forecasts On Illumina Following Upbeat Results
12:02pm, Friday, 01'st Aug 2025
Illumina, Inc. ILMN reported better-than-expected earnings for the second quarter on Thursday.
Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript
01:25am, Friday, 01'st Aug 2025
Illumina, Inc. (NASDAQ:ILMN ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Ankur Dhingra - Chief Financial Officer Brian Blanchett - VP of Finance & Treasurer and Int
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics
07:31pm, Thursday, 31'st Jul 2025
Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
06:36pm, Thursday, 31'st Jul 2025
Illumina (ILMN) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.36 per share a year ago.
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
04:05pm, Thursday, 31'st Jul 2025
Revenue of $1.06 billion for Q2 2025, down 3% from Q2 2024 on both a reported and constant currency basis GAAP operating margin of 20.2% and non-GAAP operating margin of 23.8% for Q2 2025 GAAP diluted
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics
10:15am, Wednesday, 30'th Jul 2025
Besides Wall Street's top-and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
09:15am, Wednesday, 30'th Jul 2025
Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina's growing research and clinic
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Thursday, 24'th Jul 2025
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illumina Stock: What Went Wrong And Why It's Best To Stay Away
07:45am, Thursday, 17'th Jul 2025
Illumina Inc. ILMN is currently in Phase 17 of its 18-phase Adhishthana Cycle on the weekly chart. A detailed structural analysis using the Adhishthana Principles reveals deeper issues that go beyond
